你即將離開本站

並前往https://www.businesswire.com/news/home/20190118005070/en/Obsidian-Therapeutics-Announces-Strategic-Collaboration-with-Celgene-to-Develop-Novel-Cell-Therapies-with-Tunable-Immunomodulatory-Factors-Opening-Potential-for-CAR-T-and-Other-Cellular-Medicines-in-New-Settings

Obsidian Therapeutics Announces Strategic Collaboration ...

Obsidian Therapeutics announces strategic collaboration with Celgene to develop novel cell therapies with tunable immunomodulatory factors.

確定！ 回上一頁

查詢 「Celgene」的人也找了：

  1. celgene台灣
    2.
  2. celgene中文
    3.
  3. bristol-myers squibb中文
    4.
  4. nyse: bmy
    5.
  5. Juno Therapeutics
    6.
  6. Novartis
    7.
  7. BMS hk
    8.
  8. Pfizer
    9.